623 results on '"Falk, Christine S."'
Search Results
2. An integrated cell atlas of the lung in health and disease
3. Correction to: Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors
4. Plasma immune signatures can predict rejection-free survival in the first year after pediatric liver transplantation
5. Pulmonary immune profiling of SIDS: impaired immune maturation and age-related cytokine imbalance
6. Adaptive NK cells undergo a dynamic modulation in response to human cytomegalovirus and recruit T cells in in vitro migration assays
7. No value of non‐selective beta‐blockers after TIPS‐insertion.
8. Effect of a biomimetic pathogen adsorbing device on inflammatory biomarkers in COVID‐19 patients.
9. SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study
10. Combined high-throughput library screening and next generation RNA sequencing uncover microRNAs controlling human cardiac fibroblast biology
11. CRELD1 modulates homeostasis of the immune system in mice and humans
12. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
13. Back signaling of HLA class I molecules and T/NK cell receptor ligands in epithelial cells reflects the rejection-specific microenvironment in renal allograft biopsies
14. Transplant arteriosclerosis in humanized mice reflects chronic lung allograft dysfunction and is controlled by regulatory T cells
15. Correction to: Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors
16. Scalable generation of functional human iPSC-derived CAR-macrophages that efficiently eradicate CD19-positive leukemia
17. Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19
18. CD14highCD16+ monocytes are the main producers of Interleukin-10 following clinical heart transplantation
19. Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells
20. A positive feedback loop between IL-1β, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages
21. The chemokine receptor CCR7 is a promising target for rheumatoid arthritis therapy
22. Composition of ex vivo perfusion solutions and kinetics define differential cytokine/chemokine secretion in a porcine cardiac arrest model of lung preservation
23. Age-related cytokine imbalance in the thymus in sudden infant death syndrome (SIDS)
24. Distinct systemic cytokine networks in symptomatic and asymptomatic carotid stenosis
25. Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation
26. Age-related cytokine imbalance in the thymus in sudden infant death syndrome (SIDS).
27. CARDIAC TRANSPLANTATION IS ACCOMPANIED BY MAJOR CHANGES IN THE T AND NK CELL SUBSET COMPOSITION IMMEDIATELY AFTER TRANSPLANTATION
28. Immediate major dynamic changes in the T‐ and NK‐cell subset composition after cardiac transplantation
29. T Cells Going Innate
30. Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B
31. Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus Infection
32. Equally Interchangeable? How Sex and Gender Affect Transplantation
33. Soluble immune markers in the different phases of chronic hepatitis B virus infection
34. CD14high CD16+ monocytes are the main producers of Interleukin-10 following clinical heart transplantation.
35. Supplementary Figure 1 from BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma
36. Supplemental Figure 2 from CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations
37. Supplemental Figure 4 from CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations
38. Supplementary Methods and Legend from BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma
39. Supplementary Figure 3B from BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma
40. Supplemental Figure 3 from CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations
41. Supplemental Table 1 from CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations
42. Supplementary Figure 4A, B from BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma
43. Supplementary Fig. S5 from Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression
44. Supplemental Figure 1 from CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations
45. Supplementary Figure 2A from BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma
46. Supplementary Figure 5 from BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma
47. Supplementary Methods from Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression
48. Supplementary Figure 4C from BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma
49. Supplementary Data from Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines
50. Supplementary Table 1 from BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.